网络首发:2012-09-20,
纸质出版:2012
移动端阅览
腹部手术中右旋美托咪定对全凭静脉麻醉的影响[J]. 中山大学学报(医学科学版), 2012,33(5).
Effect of Dexmedetomidine on Total Intravenous Anesthesia in Patients Undergoing Abdominal Surgery[J]. Journal of Sun Yat-sen University (Medical Sciences), 2012, 33(5).
【目的】 在腹部手术中
以丙泊酚?瑞芬太尼 TCI 为基础的全凭静脉麻醉
全程复合使用右旋美托咪定
探讨其对丙泊酚用量?术后拔管时间?睁眼时间和复苏期血流动力学变化等指标的影响?【方法】入选患者随机分成实验组1(DEX1)?实验组2(DEX2)?对照组(Control)3组?DEX1组患者于15 min内输注0.5 μg/kg右旋美托咪定
随即以0.25 μg· kg-1· h-1输注右旋美托咪定至拔管;DEX2患者于15 min内输注0.5 μg/kg右旋美托咪定
随即以0.5 μg· kg-1· h-1输注右旋美托咪定至拔管;Control组同法输注生理盐水?右旋美托咪定负荷剂量完成后开始丙泊酚 TCI 输注麻醉诱导
静脉给予顺式阿曲库胺?瑞芬太尼 TCI全凭静脉麻醉维持?记录丙泊酚麻醉诱导及围术期各观察点的丙泊酚效应室浓度(Ce) 值
术中丙泊酚用量
复苏期拔管时间?睁眼时间?血流动力学数据等?【结果】 在麻醉诱导中Narcotrend 值 达到D2 时
DEX 1 组和 DEX 2 组丙泊酚用量明显少于Control组(P < 0.05)?全程丙泊酚用量3组间比较有显著性差异(P < 0.05)?围手术期各观察点丙泊酚效应室浓度DEX 1 和 DEX 2 组均明显小于Control组(P < 0.05)?麻醉复苏期停止输注丙泊酚到拔出气管导管时间3组间比较无统计学差异(P > 0.05)?停止瑞芬太尼输注到拔出气管导管时间3组间比较无统计学差异(P > 0.05)?睁眼时间DEX 1?DEX 2组均较control明显延长(P < 0.05)?麻醉复苏期血压?心率变化实验组较对照组稳定
DEX 2组尤为明显?【结论】 成人腹部手术全凭静脉麻醉全程复合较大剂量(0.5 μg·kg-1·h-1)右旋美托咪定可减少麻醉诱导和术中各观察点丙泊酚的需要量
术中可节省丙泊酚约25%;右旋美托咪定对麻醉复苏期气管拔管时间无明显影响
但剂量相关性延长睁眼时间
复苏期血流动力学指标更平稳?
【Objective】This prospective
randomized
double-blind study was designed to assess whether intraoperative infusion of dexmedetomidine can reduce the dosage of propofol
the time of extubation and opening eyes and make hemodynamic more smooth in extubation. Parameters are received in adult patients undergoing major abdominal surgery with total intravenous anesthesia. 【Methods】 Nighty patients were randomly assigned to three groups. Group T1 (n = 30) received a loading dose of dexmedetomidine 0.5 mg·kg-1 iv during 15 minutes
followed by a continuous infusion at a rate of 0.5 μg·kg-1·h-1 throughout the operation. Group T2 (n = 30) received a loading dose of dexmedetomidine 0.5 mg ?滋kg-1 iv during 15 minutes
followed by a continuous infusion at a rate of 0.25 μg·kg-1·h-1 throughout the operation. Group C(n = 30) received a volume-matched bolus and infusion of placebo (0.9% saline). The Ce values of propofol in induction
the intraoperative total amount of propofol
the recovery time from stopping propofol or remifentanil to extubation
the time from stopping remifentanil to open eyes
and the hemodynamic in extubation were recorded.【Results】 The induction doses of propofol in group T1 [effect site concentrations:(1.5 ± 0.8)μg/mL] and group T2 [effect site concentrations: (1.6 ± 0.5)μg/mL] were significantly lower than that in group C [effect site concentrations: (2.2 ± 0.9) μg/mL
P<0.05]. In addition
the effect site concentrations of propofol at every intraoperative observation points in group T1 and T2 were significantly lower than those in group C (P < 0.05). The total dose of propofol was significantly different (P < 0.05)
(1399.7 ± 410.5) mg in group C
(1312.1 ± 627.3) mg in group T1 and (1048.0 ± 461.0)mg in group T2. The time from stopping infused propofol (TSP) [group C:(26.5 ± 8.8)min; group T1:(36.0 ± 12.8)min; group T2:(33.0 ± 7.6)min)] and from stopping remifentanil (TSR) to extubation [group C:(12.4 ± 7.4) min; group T1: [(17.1 ± 9.9) min; group T2: (16.0 ± 7.9) min] were not significantly different (P > 0.05). The time to opening eye in group T1 [(22.1 ± 9.5) min] and T2 [(37.2 ± 7.3)min] were significantly longer than that in control group [(13.1 ± 4.8)min
P < 0.05]. The blood pressure and heart rate were more stable in group T1 and T2 than in control group during anesthesia recovery period. 【Conclusion】 Continuous iv dexmedetomidine during abdominal surgery decreased the requirements of propofol in induction and every intraoperative observation points and the dose of propofol reduced about 25%. Dexmedetomidine did not affect the time of tracheal extubation but prolong the time of opening eyes. The hemodynamic parameters were more stable during anesthesia recovery period when dexmedetomidine was co-administrated.
0
浏览量
499
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
